JPRN-UMIN000006390已完成3 期
Phase III clinical trial in determining treatment strategy for patients with High grade T1 bladder cancer who have pT0 histology on the second TUR (JCOG1019, BC pT0 PhaseIII) - Phase III clinical trial in determining treatment strategy for patients with High grade T1 bladder cancer who have pT0 histology on the second TUR (JCOG1019, BC pT0 PhaseIII)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 260 人开始时间: 2011年9月22日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •First registration (no exclusion criteria at second registration) 1. Simultaneous or metachronous (within 5 years) double cancers. 2. Infectious disease (including tuberculosis) to be treated. 3. Body temperature of 38C or higher. 4. Positive anti-HIV antibody. 5. Women during pregnancy or breast-feeding. 6. Psychiatric diseases. 7. Systemic and continuous steroids medication. 8. History of severe brain ischemia or myocardial infarction within 6 months. 9. History of systemic anaphlactoid reaction for BCG.
研究者
相似试验
进行中（未招募）
不适用
Confirmatory study to evaluate the efficacy and safety of chondroitin sulphate and glucosamine sulphate in combination in the treatment of patients with osteoarthritis of the knee compared to placebo.EUCTR2013-000444-26-ESTedec-Meiji Farma, S.A.
招募中
3 期
Randomized phase III clinical trial on the therapeutic effect of Cellm-001 for newly diagnosed glioblastoma.glioblastomaD005909JPRN-jRCT2031200153Muragaki Yoshihiro112
招募中
3 期
A clinical trial of risk-stratification and gemtuzumab ozogamicin combined post-induction chemotherapy for children with AMD015470Acute Myeloid LeukemiaJPRN-jRCTs041210015Tomizawa Daisuke500
已完成
3 期
Phase III Comparative Clinical Trial of Treatment Schedules for Oral UFT/LV Therapy as Postoperative Adjuvant Chemotherapy for Stage IIB/III Colorectal Cancercolorectal cancerJPRN-C000000245Japanese Foundation for Multidisciplinary Treatment of Cancer840
已完成
3 期
A Phase III randomized controlled clinical trial of CARBOPLATIN and PACLITAXEL(OR GEMCITABINE) alone or in combination with BEVACIZUMAB (NSC #704865, IND #7921) followed by BEVACIZUMAB and secondary cytoredutive surgery in platinum sensitive, recurrent ovarian, peritoneal primary and fallopian tube cancer.PLATINUM-SENSITIVE, RECURRENT OVARIAN, PERITONEAL PRIMARY AND FALLOPIAN TUBE CANCERJPRN-UMIN000003682Gynecologic Oncology Group1,050